CA01 Target Identification vs TNBC
CA01 - Target Identification
Together with our collaborators, we have found a new therapeutic target for TNBCs that we are currently patenting..
Together with our collaborators, we have found a new therapeutic target for TNBCs that we are currently patenting..
The Ministry of Science and Technology has granted Torres Quevedo research grant for our researcher Elisa Poyatos.
We once again attend the B-venture 2021 event in Bilbao this time under the sponsorship of DeustoEmprende.
CancerAppy raised a pre-seed round of € 50K
Cancerappy has been selected as one of the 11 most innovative companies in artificial intelligence in the Basque Country.